Literature DB >> 27407872

Significance of Tuberculin Testing in HIV Infection: An Indian Perspective.

Mps Sawhney1, Y K Sharma2.   

Abstract

BACKGROUND: Tuberculin skin testing (TST) is a reliable tool in the diagnosis of tuberculous infection and is important in its control. However, it may be false negative in immunocompromised patients like HIV-infected.
METHODS: We examined the pattern of TST results in 523 newly diagnosed HIV-positive patients. CD4, CD8 and absolute lymphocyte counts were done by flowcytometry in 63 of these cases.
RESULTS: 56 (44.10%), 15 (11.81%) and 56 (44.10%) of the 127 cases with tuberculosis and 293 (73.99%), 41 (10.35%) and 62 (15.66%) of the 396 cases without any clinical evidence of tuberculosis showed TST results of 0-4, 5-9 and = or > 10 mm respectively. Significantly more (P<0.05) number of cases with TST of = or > 10mm and significantly lesser (P<0.05) number of cases with TST of 0-4 mm are likely to develop tuberculosis. The average CD4+lymphocyte count was found to be significantly lower in cases with nil TST results than with = or >10mm. HIV infected cases associated with tuberculosis with induration on TST had average CD4 counts of 129.5 as compared to 246.3/cmm in those without tuberculosis.
CONCLUSION: In India where both these diseases are endemic, tuberculosis may develop during early HIV infection, while the body's immunity is still largely unimpaired and TST shows = or >10mm results in almost 45% of our cases. In another 45% with TST of 0-4mm, the CD4+ lymphocyte count is likely to be lower than 200/cmm. In those with nil induration, TST of 5-9 mm cannot be taken as an independent marker for suspecting tuberculosis in the HIV infected. Hence we recommend that all cases with TST of = or >10mm and cases with nil induratrion with CD4+ count of <200/cmm should be considered as high-risk for developing tuberculosis.

Entities:  

Keywords:  HIV infection; Tuberculin skin test

Year:  2011        PMID: 27407872      PMCID: PMC4921940          DOI: 10.1016/S0377-1237(06)80047-X

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  17 in total

Review 1.  Tuberculosis in the United States.

Authors:  H L Rieder; G M Cauthen; G D Kelly; A B Bloch; D E Snider
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

2.  Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.

Authors:  S Diagbouga; F Fumoux; E Ledru; P T Sanou; D Barro; G Marchal
Journal:  Int J Tuberc Lung Dis       Date:  1998-04       Impact factor: 2.373

3.  Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.

Authors:  M N Gourevitch; D Hartel; P A Selwyn; E E Schoenbaum; R S Klein
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

4.  Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.

Authors:  E M Janis; D W Allen; M J Glesby; L A Carey; L M Mundy; R Gopalan; R E Chaisson
Journal:  Am J Med       Date:  1996-02       Impact factor: 4.965

5.  Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.

Authors:  José J Portu; Mikel Aldamiz-Etxebarria; José M Agud; José M Arévalo; María J Almaraz; Cándido Ayensa
Journal:  Addict Biol       Date:  2002-04       Impact factor: 4.280

6.  Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.

Authors:  H Yanai; W Uthaivoravit; T D Mastro; K Limpakarnjanarat; P Sawanpanyalert; R H Morrow; P Nieburg
Journal:  Int J Tuberc Lung Dis       Date:  1997-10       Impact factor: 2.373

7.  Clinical and laboratory profile of AIDS in India.

Authors:  A Kaur; P G Babu; M Jacob; C Narasimhan; A Ganesh; N K Saraswathi; D Mathai; B M Pulimood; T J John
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

8.  Natural history of human immunodeficiency virus disease in southern India.

Authors:  N Kumarasamy; Suniti Solomon; Timothy P Flanigan; R Hemalatha; S P Thyagarajan; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2002-12-09       Impact factor: 9.079

Review 9.  Tuberculosis skin testing and preventive therapy.

Authors:  C A Hanson; L B Reichman
Journal:  Semin Respir Infect       Date:  1989-09

10.  Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study.

Authors:  L E Duncan; A M Elliott; R J Hayes; S K Hira; G Tembo; G T Mumba; S H Ebrahim; M Quigley; J O Pobee; K P McAdam
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jan-Feb       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.